CBU
PFE icon

CIBC Bancorp USA’s Pfizer PFE Stock Holding History

CIBC Bancorp USA’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5M Sell
1,475,301
-295,662
-17% -$7.73M 0.04% 306
2026
Q1 		$49.7M Buy
+1,770,963
New +$47.1M 0.07% 223
2025
Q3 		$20.1M Buy
+787,505
New +$19.4M 0.11% 153

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CIBC Bancorp USA's PFE Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Pfizer (PFE) stake by 17% in Q2 2026, selling an estimated $7.73M and leaving 1,475,301 shares worth $35.5M. The position accounts for 0.04% of the portfolio, ranked #306.

CIBC Bancorp USA first reported a position in PFE in Q3 2025 and has held it in 3 quarters since. The position peaked at $49.7M in Q1 2026. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • CIBC Bancorp USA held 1,475,301 shares of Pfizer worth $35.5M as of Q2 2026.
  • CIBC Bancorp USA sold 295,662 Pfizer shares in Q2 2026, an estimated $7.73M.
  • Pfizer made up 0.04% of CIBC Bancorp USA's portfolio in Q2 2026, its #306 holding.
  • CIBC Bancorp USA first reported a position in Pfizer in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Pfizer position peaked at $49.7M in Q1 2026.
  • 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.